MOA Life Plus Co. Ltd. (KOSDAQ:142760)
South Korea · Delayed Price · Currency is KRW 1,051.00
+55.00 (5.52%)
At close: Apr 3, 2026
MOA Life Plus Market Cap
MOA Life Plus has a market cap or net worth of 42.89 billion as of April 2, 2026. Its market cap has decreased by -9.86% in one year.
Market Cap
42.89B
Enterprise Value
41.24B
Revenue
11.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,051.00
Market Cap Chart
Since July 7, 2016, MOA Life Plus's market cap has decreased from 97.39B to 42.89B, a decrease of -55.96%. That is a compound annual growth rate of -8.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 42.89B | -38.13% |
| Dec 30, 2025 | 69.32B | 51.95% |
| Dec 30, 2024 | 45.62B | -33.64% |
| Dec 28, 2023 | 68.75B | -38.77% |
| Dec 29, 2022 | 112.27B | -53.08% |
| Dec 30, 2021 | 239.30B | 38.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 62.68B |
| ADBiotech | 61.01B |
| IMGT Co.,Ltd. | 59.29B |
| Parataxis Korea | 47.73B |
| J2KBIO | 44.67B |
| NGeneBio | 43.93B |
| SCM Lifescience | 35.67B |
| Kainos Medicine | 35.56B |